| Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization BA Cotton, OL Gunter, J Isbell, BK Au, AM Robertson, JA Morris Jr, ... Journal of Trauma and Acute Care Surgery 64 (5), 1177-1183, 2008 | 567 | 2008 |
| High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants P Razavi, BT Li, DN Brown, B Jung, E Hubbell, R Shen, W Abida, K Juluru, ... Nature medicine 25 (12), 1928-1937, 2019 | 541 | 2019 |
| Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival OL Gunter Jr, BK Au, JM Isbell, NT Mowery, PP Young, BA Cotton Journal of Trauma and Acute Care Surgery 65 (3), 527-534, 2008 | 441 | 2008 |
| Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ... Annals of Oncology 29 (8), 1853-1860, 2018 | 379 | 2018 |
| The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery JM Isbell, RA Tamboli, EN Hansen, J Saliba, JP Dunn, SE Phillips, ... Diabetes care 33 (7), 1438-1442, 2010 | 322 | 2010 |
| AKI associated with cardiac surgery RH Thiele, JM Isbell, MH Rosner Clinical Journal of the American Society of Nephrology 10 (3), 500-514, 2015 | 314 | 2015 |
| Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer V Anagnostou, PM Forde, JR White, N Niknafs, C Hruban, J Naidoo, ... Cancer research 79 (6), 1214-1225, 2019 | 258 | 2019 |
| Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer MJ Bott, SC Yang, BJ Park, PS Adusumilli, VW Rusch, JM Isbell, ... The Journal of thoracic and cardiovascular surgery 158 (1), 269-276, 2019 | 250 | 2019 |
| Risk of malignancy in resected cystic tumors of the pancreas≤ 3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report CJ Lee, J Scheiman, MA Anderson, OJ Hines, HA Reber, J Farrell, ... Journal of Gastrointestinal Surgery 12, 234-242, 2008 | 223 | 2008 |
| Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non–small-cell lung cancer: a competing risks analysis T Eguchi, S Bains, MC Lee, KS Tan, B Hristov, DH Buitrago, MS Bains, ... Journal of Clinical Oncology 35 (3), 281, 2017 | 189 | 2017 |
| HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers BT Li, F Michelini, S Misale, E Cocco, L Baldino, Y Cai, S Shifman, HY Tu, ... Cancer discovery 10 (5), 674-687, 2020 | 176 | 2020 |
| Implementing a thoracic enhanced recovery program: lessons learned in the first year LW Martin, BM Sarosiek, MA Harrison, T Hedrick, JM Isbell, AS Krupnick, ... The Annals of thoracic surgery 105 (6), 1597-1604, 2018 | 143 | 2018 |
| Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium BT Li, F Janku, B Jung, C Hou, K Madwani, R Alden, P Razavi, ... Annals of Oncology 30 (4), 597-603, 2019 | 138 | 2019 |
| Obesity increases risk‐adjusted morbidity, mortality, and cost following cardiac surgery RK Ghanta, DJ LaPar, Q Zhang, V Devarkonda, JM Isbell, LT Yarboro, ... Journal of the American Heart Association 6 (3), e003831, 2017 | 132 | 2017 |
| A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers JK Sabari, M Offin, D Stephens, A Ni, A Lee, N Pavlakis, S Clarke, ... JNCI: Journal of the National Cancer Institute 111 (6), 575-583, 2019 | 121 | 2019 |
| Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality Y Hu, TL McMurry, JM Isbell, GJ Stukenborg, BD Kozower The Journal of thoracic and cardiovascular surgery 148 (5), 2261-2267. e1, 2014 | 118 | 2014 |
| Preoperative anemia versus blood transfusion: which is the culprit for worse outcomes in cardiac surgery? DJ LaPar, RB Hawkins, TL McMurry, JM Isbell, JB Rich, AM Speir, ... The Journal of thoracic and cardiovascular surgery 156 (1), 66-74. e2, 2018 | 115 | 2018 |
| Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors MJ Bott, J Cools-Lartigue, KS Tan, J Dycoco, MS Bains, RJ Downey, ... The Annals of thoracic surgery 106 (1), 178-183, 2018 | 110 | 2018 |
| The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma R Caso, F Sanchez-Vega, KS Tan, B Mastrogiacomo, J Zhou, GD Jones, ... Journal of Thoracic Oncology 15 (12), 1844-1856, 2020 | 97 | 2020 |
| Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers M Offin, D Feldman, A Ni, ML Myers, WV Lai, E Pentsova, A Boire, ... Cancer 125 (24), 4380-4387, 2019 | 97 | 2019 |
